NSRGY - Nestlé divests peanut allergy treatment business Palforzia
2023-09-04 06:43:14 ET
More on Nestlé S.A.
- Nestle Q2 Earnings: Volume And Gross Margin Should Improve In H2 2023
- Nestle: H1 2023 Results Are Out, Optimization Is On Track
- Nestle S.A. ( OTCPK:NSRGY ) Q2 2023 Earnings Call Transcript
- Nestlé S.A. 2023 Q2 - Results - Earnings Call Presentation
- Nestlé lands bull ratings from HSBC after new outlook flips the script
- Dividend scorecard for Nestlé S.A.
For further details see:
Nestlé divests peanut allergy treatment business Palforzia